Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis-Reference-Cited by-同舟云学术

Mary B. Walker, M.D. and the pioneering use of prostigmin to treat myasthenia gravis

Published:1997-03 Issue:1-2 Volume:93 Page:125-134
ISSN:0012-4486
Container-title:Documenta Ophthalmologica
language:en
Short-container-title:Doc Ophthalmol

Author:

Keeney Arthur H.,Keeney Virginia T.

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/BF02569052.pdf

Reference12 articles.

1. Walker, M. B. (letter) Treatment of myasthenia gravis with physostigmine. Lancet 1936, pp. 1200–1201, June 2, 1934.

2. Pritchard, E. A. B. and Walker, M. B. The effect of prostigmin on the symptoms and on the myogram in myasthenia gravis. Proc. Physiol. Soc. 84: 35P-36P, (March 16) 1935

3. Hamill, P and Walker, M. B. The action of ‘prostigmin’ (Roche) in neuro-muscular disorders. Proc. Physiol. Soc. 84: 36P-37P, (March 16) 1935.

4. Walker, M. B. (MRCP) Case showing the effect of Prostigmin on myasthenia gravis. Proc. Royal Soc. of Med. 28 (Part I): 759–761, April 1935.

5. Laurent, L. P. E. and Walker, M. B. Oral and parental administration of Prostigmin and its analogues in myasthenia gravis. Lancet 1: 1457–1459, (June 27) 1936.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis;Neuropharmacology;2021-01

2. Henry R. Viets, MD, and the History of Myasthenia Gravis;Neurology;2020-11-20

3. The Mary Walker effect: Mary Broadfoot Walker;Journal of the Royal College of Physicians of Edinburgh;2019

4. Chapter 1 The most vulnerable synapse: historic aspects of neuromuscular junction disorders;Handbook of Clinical Neurology;2008

5. Special Section On Myasthenia;Journal of the History of the Neurosciences;2005-06